Suncoast Equity Management »

Neurocrine Biosciences shares owned by Suncoast Equity Management

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Suncoast Equity Management from 13F filings

Historical chart of Suncoast Equity Management investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by Suncoast Equity Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by Suncoast Equity Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $721k 5.1k 141.83

More positions owned by Suncoast Equity Management

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Booking Holdings (BKNG)
Alphabet Cap Stk Cl C (GOOG)
Visa Com Cl A (V)
Intuit (INTU)
Apple (AAPL)
Eli Lilly & Co. (LLY)
Alphabet Cap Stk Cl A (GOOGL)
Stryker Corporation (SYK)
McKesson Corporation (MCK)
Mastercard Incorporated Cl A (MA)
salesforce (CRM)
Broadcom (AVGO)
Meta Platforms Cl A (META)

View all positions for Suncoast Equity Management

Top funds holding Neurocrine Biosciences

BlackRock
Vanguard Group
Dodge & Cox
Jpmorgan Chase & Co
State Street Corporation
AQR Capital Management
Renaissance Technologies
Geode Capital Management
Wellington Management Company
Bellevue Group
Bnp Paribas Investment Partners
Thomas Stevens, CFA"
Northern Trust
Deerfield Management Company
Norges Bank Investment Management

View all funds holding Neurocrine Biosciences